Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2015
Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITKIdit Sagiv-Barfi, Holbrook E K Kohrt, Debra K Czerwinski, et al.Science Translational Medicine|February 2, 2018
Eradication of spontaneous malignancy by local immunotherapyIdit Sagiv-Barfi, Debra K Czerwinski, Shoshana Levy, et al.The Journal of Experimental Medicine|May 25, 2019
CD81 is a novel immunotherapeutic target for B cell lymphomaFelipe Vences-Catalán, Chiung-Chi Kuo, Ranjani Rajapaksa, et al.Blood|September 30, 2010
A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumorsMatthew J Goldstein, Bindu Varghese, Joshua D Brody, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 31, 2023
Targeted TLR9 Agonist Elicits Effective Antitumor Immunity against Spontaneously Arising Breast TumorsCaitlyn L Miller, Idit Sagiv-Barfi, Patrick Neuhöfer, et al.Proteomics|March 2, 2018
T-Cell Immunopeptidomes Reveal Cell Subtype Surface Markers Derived From Intracellular ProteinsNiclas Olsson, Liora M Schultz, Lichao Zhang, et al.Leukemia & Lymphoma|January 7, 2009
Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphomaJohn M Timmerman, Julie M Vose, Debra K Czerwinski, et al.Cell Chemical Biology|November 14, 2021
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regressionCaitlyn L Miller, Idit Sagiv-Barfi, Patrick Neuhöfer, et al.Proceedings of the National Academy of Sciences of the United States of America|June 15, 2010
B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progressionJonathan M Irish, June H Myklebust, Ash A Alizadeh, et al.Cancer Cytopathology|November 15, 2021
Serial FNA allows direct sampling of malignant and infiltrating immune cells in patients with B-cell lymphoma receiving immunotherapyKelly L Mooney, Debra K Czerwinski, Tanaya Shree, et al.Pageof 5